KCNK3 and atrial fibrillation: In conclusion, the TASK-1 channel represents a promising target for future therapy of AF since it is atrial-specific expressed, which reduces the risk of pro-arrhythmic effects in the ventricle, and has a strong influence on atrial APD in AF patients (Ravens, 2010; Schmidt et al., 2014b, 2015).